US Patent 10960060 Treatment of cardiac arrhythmia using botulinum toxin
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+415 characters)
Article
Patent abstract
A method for treating arrhythmia in a patient in need thereof comprises administering botulinum toxin to the patient. Botulinum toxin may be administered by subcutaneous or intradermal injection. The subcutaneous or intradermal injection may be administered to and/or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and/or a sacral nerve of the patient.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Roland M. Williams0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
109600600
Date of Patent
March 30, 2021
0Patent Application Number
168759450
Date Filed
May 15, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10960060 Treatment of cardiac arrhythmia using botulinum toxin
Infobox
Is a
Patent jurisdiction
Patent number
10960060
Date of patent
March 30, 2021
Patent application number
16875945
Date Filed
May 15, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 10960060 Treatment of cardiac arrhythmia using botulinum toxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
